SourceStalecollected in 8m

Ultra-Flexible Neural Implant Electrodes Developed

Ultra-Flexible Neural Implant Electrodes Developed
PostLinkedIn
💰Read original on 钛媒体
#neural-interfaces#bioelectronics#bci-hardwareflexible-implantable-electrodesneurosoft-bioelectronics

💡100k x flexible neural electrodes unlock advanced BCI for AI neurotech.

⚡ 30-Second TL;DR

What Changed

Neurosoft Bioelectronics creates flexible electrodes for neural system interaction

Why It Matters

This could enable safer, more effective brain-computer interfaces, accelerating AI-driven neurotech research and prosthetics.

What To Do Next

Prototype BCI systems using Neurosoft's flexible electrodes for improved neural signal stability.

Who should care:Researchers & Academics

Key Points

  • Neurosoft Bioelectronics creates flexible electrodes for neural system interaction
  • Electrodes up to 100,000 times more flexible than clinical standards
  • Developed by Swiss medical firm for implantable applications

🧠 Deep Insight

Background and context from public sources — not the original article. 6 sources cited.

🔑 Enhanced Key Takeaways

  • Neurosoft Bioelectronics' SOFT ECoG™ electrodes have been successfully tested in two human patients during epilepsy surgery at University Medical Center Utrecht in February 2025, detecting high-frequency oscillations for precise epileptic tissue identification[2].
  • The company, an EPFL spin-off from the Laboratory for Soft Bioelectronic Interfaces, won 1st Prize in the AI Vertical at Swisstech Deep Tech Pitch Battle and the Startup World Cup Las Vegas Regional at CES 2026[3][6].
  • SOFT ECoG™ supports both neural recording and stimulation for up to 30 days sub-chronically, with plans to expand from 30 to 64 electrodes and increase density based on initial trials[1][5].

🛠️ Technical Deep Dive

  • SOFT ECoG™ features 64 sensing channels in stretchable material, 1,000 to 100,000 times softer than conventional electrodes, with electrodes 100 times smaller in feature size[1][2][4].
  • Electrodes are 1,000 times softer and two times thinner than market alternatives, manufactured using semiconductor-inspired processes for high precision, reduced manual labor, and wafer-scale production[1][4].
  • Designed for subdural placement on brain surface, enabling high-resolution recordings of epilepsy biomarkers like fast ripples and high-frequency oscillations[2][5].

🔮 Future ImplicationsAI analysis grounded in cited sources

Obtain European regulatory approval by 2027
A 12-patient study at UMC Utrecht is underway following initial trials to validate the technology for clinical use in epilepsy surgery centers[2].
Enable closed-loop tinnitus treatment via SOFT TINNIT™
Neurosoft is developing a fully implantable system targeting brain areas for neuromodulation to suppress tinnitus in 120 million affected individuals[5].
Power non-invasive upper-limb exosuits via Synapsuit BCI
In collaboration with Wyss Center, the project decodes brain signals from soft interfaces to control wearable exosuits for motor disabilities[5].

Timeline

2023
Neurosoft Bioelectronics founded as EPFL spin-off from Laboratory for Soft Bioelectronic Interfaces[6]
2025-02
First two human trials of 64-channel SOFT ECoG™ during epilepsy surgery at UMC Utrecht[2]
2025-12
Initial human testing of flexible brain implant reported, planning expansion to 64 electrodes[1]
2026-01
Wins awards at CES Las Vegas including Startup World Cup Regional for SOFT ECoG™[3]
2026-03
Announces ultra-flexible electrodes 100,000 times more flexible than clinical standards[article]
📰

Weekly AI Recap

Read this week's curated digest of top AI events →

👉Related Updates

AI-curated news aggregator. All content rights belong to original publishers.
Original source: 钛媒体

This is a summary, not the original. Read the source, or get the weekly briefing.

The weekly digest

One email a week. Unsubscribe anytime.